What is Antiepileptic Drugs?
Epilepsy is a nervous system (neurological) disorder in which brain movement becomes anomalous, causing seizures or periods of abnormal behavior, sensations, and in some cases loss of awareness. Anyone can develop epilepsy. Epilepsy affects both male and female of all races, ethnic foundations and ages. Seizure symptoms can vary widely. Some people with epilepsy basically gaze blankly for some seconds during a seizure, while others repeatedly jerk their arms or legs. Having a single seizure doesn't mean you have got epilepsy. At least two unprovoked seizures are generally required for an epilepsy diagnosis. Antiepileptic drugs are medications that decrease the recurrence of epileptic seizures. Antiepileptic drugs (AEDs) are progressively utilized for the treatment of several non-epileptic neurological conditions & psychiatric disorders.
The market study is broken down and major geographies with country level break-up.
The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market in the near future. Players are anticipated to focus on the development of new compounds, which is likely to encourage the growth of the global market throughout the forecast period. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Antiepileptic Drugs market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
GW Pharmaceuticals plc (United Kingdom), Jazz pharmaceuticals (Ireland), Eisai Co., Ltd (Japan), Novartis AG (Switzerland), GlaxoSmithKline Plc (United Kingdom), Johnson & Johnson Service, Inc. (United States), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer, Inc. (United States) and Sanofi S.A. (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Sumitomo Dainippon Pharma Co. Ltd. (Japan), Mylan N.V. (United States), Bausch Health Companies Inc. (United States) and UCB S.A. (Belgium).
AdvanceMarketAnalytics has segmented the market of Global Antiepileptic Drugs market by Type, Application and Region.
On the basis of geography, the market of Antiepileptic Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug, the sub-segment i.e. First Generation will boost the Antiepileptic Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Route of Administration, the sub-segment i.e. Oral will boost the Antiepileptic Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Antiepileptic Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Spectrum, the sub-segment i.e. Narrow Spectrum will boost the Antiepileptic Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On May 5, 2021- Jazz Pharmaceuticals announced the completion of acquisition of GW Pharmaceuticals plc, a pioneer in the science, development and commercialization of cannabinoid-based prescription drugs.
On 20 April 2021, GW Pharmaceuticals plc, a world pioneer in discovering, developing & delivering regulatory approved cannabis-based medications, announced that the European Commission (EC) has approved the Type II variation application for EPIDYOLEX® (cannabidiol) as an adjunctive treatment of seizures related with TSC, for patients two years of age & older. and Eisai Co., Ltd. announced that it has been received approval from the European Commission for the use of its in-house built and developed anti-epileptic agent (AED) Fycompa® in the treatment of pediatric patients.
- Increased R&D Activities by Pharmaceutical Companies
- Increasing Neurological Disorder
- Advancement in Drug Modification
- Advancement in Chemical Compounds of the medicines
- Rising generic competition
- Increasing Side-Effects of Medicine
- Shortage of Medicines in the Pharmacies
Key Target AudienceDrugs Manufacturers, Industry Association, Downstream Vendors, Marketing & Consulting firms, Venture Capitalists, Government & Regulatory Bodies and Traders/Suppliers & Distributors
About ApproachTo evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):
1. What all players are profiled in the study?
The standard version of the report profiles players such as GW Pharmaceuticals plc (United Kingdom), Jazz pharmaceuticals (Ireland), Eisai Co., Ltd (Japan), Novartis AG (Switzerland), GlaxoSmithKline Plc (United Kingdom), Johnson & Johnson Service, Inc. (United States), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer, Inc. (United States) and Sanofi S.A. (France) etc.
2. What would be the Market Size of Antiepileptic Drugs Market by 2026?
Analysts at AMA estimates Antiepileptic Drugs Market to reach USDXXX by 2026.
3. Can we have customized study for Antiepileptic Drugs Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.